Axogen Inc
USUSDAxogen Inc (US:AXGN) — Biotechnology: Electromedical & Electrotherapeutic Apparatus. Брой борси, на които се търгуват акциите на компанията: 2. На тази страница — цена и график, дивиденти, най-големи акционери и история на броя на акциите.
За компанията
- Уебсайт
- axogeninc.com
- Връзки с инвеститорите
- ir.axogeninc.com/
- Сектор
- Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Централа
- ALACHUA, United States
- Изпълнителен директор
- Michael D. Dale
- Служители
- 622
- Акции в обращение
- 58.67 млн към 2026-07-27
- Свободно търгуеми акции
- 49.06 млн
- Пазарна капитализация
- 2.12 млрд USD
- Инсайдери
- 1.98%
- Институционални инвеститори
- 98.6%
- Отрасъл (SIC)
- Electromedical & Electrotherapeutic Apparatus
- FCF
- 8.60 млн USD
- Дълг
- 0 USDнетни парични средства
- Печалби и FCF — за 12-те месеца до 30.06.2026 (последният доклад на компанията).
Описание
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida.
Новини тази седмица
Никакви новини през последната седмица. Последни новини: 01.10.2026.
Най-големи притежатели
| Притежател | Дял | Акции | Дата на доклада |
|---|---|---|---|
| Blackrock Inc. | 8.22% | 4.42 млн | 2026-06-30 |
| First Light Asset Manage… | 5.11% | 2.75 млн | 2026-06-30 |
| Morgan Stanley | 5.11% | 2.75 млн | 2026-06-30 |
| Vanguard Capital Managem… | 4.2% | 2.26 млн | 2026-06-30 |
| Artemis Investment Manag… | 3.31% | 1.78 млн | 2026-09-30 |
| VANGUARD INDEX FUNDS-Van… | 2.97% | 1.6 млн | 2026-06-30 |
| Polar Capital Holdings P… | 2.79% | 1.5 млн | 2026-06-30 |
| Wellington Management Gr… | 2.59% | 1.39 млн | 2026-06-30 |
| Geode Capital Management… | 2.56% | 1.38 млн | 2026-06-30 |
| Citadel Advisors Llc | 2.53% | 1.36 млн | 2026-06-30 |
| iShares Trust-iShares Ru… | 2.52% | 1.35 млн | 2026-08-31 |
| Wasatch Advisors LP | 2.41% | 1.3 млн | 2026-06-30 |
| Manager Directed Portfol… | 2.04% | 1.1 млн | 2026-07-31 |
| VANGUARD INDEX FUNDS-Van… | 1.13% | 609 728 | 2026-06-30 |
| T. Rowe Price New Horizo… | 1.09% | 588 200 | 2026-06-30 |
| Fidelity Salem Street Tr… | 1.07% | 575 481 | 2026-07-31 |
| BARON INVESTMENT Fd.S TR… | 0.99% | 532 900 | 2026-06-30 |
| Fidelity Capital Trust-F… | 0.98% | 526 000 | 2026-07-31 |
| iShares Trust-iShares Ru… | 0.92% | 493 391 | 2026-08-31 |
| Vanguard Explorer Fund | 0.8% | 428 087 | 2026-07-31 |
| DEVINNEY ERICK WAYNE (Of… | ≈0.49% | 262 781 | 2026-03-16 |
| MCBRIDE-WENDELL AMY A. (… | ≈0.2% | 107 976 | 2026-08-11 |
| QUACKENBUSH DORIS (Offic… | ≈0.17% | 92 416 | 2026-05-07 |
| NEELS GUIDO J (Director) | ≈0.16% | 86 743 | 2025-06-09 |
| KEMP JENS SCHROEDER (Off… | ≈0.13% | 72 451 | 2026-05-07 |
| HARTLEY LINDSEY MARIE (C… | ≈0.12% | 65 146 | 2026-05-07 |
| DALE MICHAEL D (Chief Ex… | ≈0.12% | 63 537 | 2025-12-10 |
| LEVINE ALAN M. (Director… | ≈0.09% | 50 893 | 2026-06-18 |
| BEGAN MARC A. (General C… | ≈0.09% | 50 135 | 2026-08-10 |
| THOMAS PAUL G (Director) | ≈0.06% | 32 395 | 2026-06-18 |
